Latest Drug Approvals news
.jpg)
FDA Approves Vyloy for Advanced Gastric or Gastroesophageal Junction Cancer
posted October 23rd
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Vyalev for Advanced Parkinson Disease
posted October 22nd
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Dupixent for Chronic Obstructive Pulmonary Disease
posted October 1st
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves Miplyffa for Treatment of Niemann-Pick Disease, Type C
posted September 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Most Speakers at FDA Advisory Committee Meetings Support Drug Approval 
Oral Engasertib Safe for Hereditary Hemorrhagic Telangiectasia 
Adenotonsillectomy Safe in Children With Down Syndrome, Other Genetic Syndromes 
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines Related Articles
FDA Picks George Tidmarsh to Head Center for Drug Evaluation and Research 
Approved-Label Populations for New Drugs Broader Than Trial Populations 
FDA Expands Indication of Dust Mite Allergy Drug to Include Young Children Monthly Specialist Briefings
Stay Connected
